CIK 0000822370
- Non-accelerated filer
- Smaller reporting company
Emmaus Life Sciences, Inc.
Sign in to watch- Ticker
- EMMA
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870419387
- Phone
- +1 310-214-0065
- Business address
- 21250 HAWTHORNE BOULEVARD, SUITE 800, TORRANCE, CA, 90503
- Former names
- MYnd Analytics, Inc., CNS RESPONSE, INC., STRATIVATION, INC., SalesTactix, Inc., AGE RESEARCH INC
- 4 Open-market buy Vice Chairman & COO bought 1,000 shares at $3.35 ($3,350)
- 4 Open-market buy Chairman and CEO bought 19,500 shares at an average $3.38 ($65,998)
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 3/A Insider 3/A
- 3 Insider Initial Statement of Ownership
- 3/A Insider 3/A
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 200,000 shares at $1.25 ($250,800)
- 4 Grant or award Director acquired 50,000 shares (grant or award)
- 4 Open-market buy Director bought 100,000 shares at $1.68 ($167,600)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
Page 11 of 25 · 488 filings